Studies are currently underway in depression, major depressive disorder and post-traumatic stress disorder (PTSD). From three sites, Cedar helps drug developers design and execute their clinical trials, the goal being to bring as many therapies to market as possible. Novamind's other arm is a contract research organization (CRO), Cedar Clinical Research, led by Robison and Chief Scientific Officer Paul Fielding.
![novamind psychedelics novamind psychedelics](https://equity.guru/wp-content/uploads/2021/03/132825345_1120252458414291_2261611071434882994_o-750x549.jpg)
Novamind's clinics are busier than ever now due to the COVID-19 pandemic having exacerbated the existing mental health crisis around the world. Expanding the network via acquisition, the company has six open clinics and expects to add another four this year alone. One arm develops and operates a network of psychiatric and mental health clinics throughout the U.S., all of which offer a wide of range of treatments, old and new. To tackle this goal, Novamind has two distinct but interworking operations, both founded by Novamind's Chief Medical Officer and Psychiatrist Dr. More new modalities are expected in the future, including further psychedelics MDMA, or methylenedioxymethamphetamine, is expected to be the first one legalized. "That is, people don't have access to the resources that are available now." Along with traditional offerings, those include ketamine-assisted psychotherapy, transcranial magnetic stimulation (TMS), and Spravato (S-ketamine or esketamine), the prescription version of ketamine. "Across the board, accessibility is probably the primary constraint," Conforti noted. He is a venture capital investor and company builder who has worked in numerous sectors. Its primary focus is on making it accessible to all people who need treatment for various mental health and related conditions," said Novamind CEO Yaron Conforti.
![novamind psychedelics novamind psychedelics](https://thedalesreport.com/wp-content/uploads/2021/05/Novamind-PR-Wordpress-Cover.png)
![novamind psychedelics novamind psychedelics](https://psytechglobal.com/wp-content/uploads/2020/12/Novamind-1-300x250.png)
"Novamind is a mental health-focused firm aiming to develop the clinical infrastructure needed to get psychedelic medicine to the masses. (NM:CSE) executives to discuss the company's mission and business structure. Citi Research Analyst, Neena Bitritto-Garg, began the broadcast by asking